Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Dosage in Shoulder Arthroscopy Blocks
NCT04947007Completed
- Sponsor
- Istanbul University
- Start
- Jul 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain, sponsored by Istanbul University. Primary endpoint: Visual Analogue Scale Pain Score at 48 hours. Started Jul 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04947007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04947007.